MedElevator Войти в исследования
← Поиск публикаций

DOI 10.11817/j.issn.1672-7347.2017.05.012

Медицинская библиотека · Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2017

[Effects of dexmedetomidine on perioperative cardiac adverse events in elderly patients with 
coronary heart disease].

Shen Junmei, Sun Yanjiang, Han Ding, Zhu Kangsheng, Zhao Wei

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

To investigate the effects of dexmedetomidine on perioperative cardiac adverse events in elderly patients with coronary heart disease.

Methods

Sixty elderly patients, who were diagnosed as coronary heart disease and underwent gastric cancer operation, were randomly divided into 2 groups (n=30): the dexmedetomidine group (Dex group) and the control group. In the Dex group, dexmedetomidine was administered intravenously at 0.5 μg/(kg·h) after a bolus infusion at 0.5 μg/kg for 10 min before anesthesia induction. In the control group, equal volume of normal saline was infused instead of dexmedetomidine. The 2 groups received the same anesthesia treatment. The venous bloods were collected at the preoperative 0 h and postoperative 24 h. The concentrations of cardiac troponin (cTnI), N-terminal pro-brain natriuretic peptide (NT-proBNP) and hypersensitive C-reactive protein (hs-CRP) were determined. The ECG was monitored at the above time and the postoperative incidence of cardiac adverse events was recorded.

Results

The levels of cTnI, NT-proBNP and hs-CRP in serum were elevated in the 2 groups after the operation. Compared with the control group, the levels of cTnI, NT-proBNP and hs-CRP were significantly decreased in the Dex group (P<0.05). Compared with the control group, the incidence of bradycardia were significantly increased, while the myocardial ischemia and tachycardia were significantly decreased in the Dex group during the operation (P<0.05); the incidence of silent myocardial ischemia and arrhythmia was significantly reduced at 3 days after operation in the Dex group (P<0.05).

Conclusion

Dexmedetomidine could decrease the incidence of cardiac adverse events in elderly patients with coronary heart disease.

Для цитирования: Shen Junmei, Sun Yanjiang, Han Ding, Zhu Kangsheng, Zhao Wei. [Effects of dexmedetomidine on perioperative cardiac adverse events in elderly patients with 
coronary heart disease].. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. 2017. DOI: 10.11817/j.issn.1672-7347.2017.05.012.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.